Name: CPRX Income Statement - Catalyst Pharmaceuticals Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CPRX - Catalyst Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

CPRX Income Statement - Catalyst Pharmaceuticals Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	149.4	152.6	148.4	146.6	141.4	141.8	128.7	122.7	98.5	110.6	102.7	99.6	85.4	60.8	57.2	53.1

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007	FY2006	FY2005	FY2004	FY2003	FY2002
Revenues
Revenues	597.0	589.0	491.7	398.2	214.2	140.8	119.1	102.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	2.7	1.8	2.7	4.4	3.9	3.8	3.3	3.0	2.6	2.0	83.7	4.0	3.6	4.1	8.3	4.0	3.4	5.0	4.5	4.5	3.0	4.2	3.7	4.4	4.2	6.3	4.6	4.6	3.3	8.4	4.5	3.7	3.3	3.4	2.7	2.5	2.8	2.8	2.5	2.5
Selling General & Administrative	49.3	53.4	47.5	45.9	46.9	44.2	45.9	40.7	46.9	42.0	33.6	28.4	29.7	14.1	13.6	12.9
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	17.8	18.5	15.0	14.8	14.8	11.5	14.9	12.6	19.9	-	-	-	-	-	-	-	-
Depreciation & Amortization	0.1	-	-	-	0.1	-	-	-	0.1	-	-	-	0.1	-	-	-
Amortization of Intangibles	9.7	-	-	-	9.3	-	-	-	9.3	-	-	-	6.5	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	52.0	55.2	50.1	50.3	50.8	48.0	49.2	43.7	49.5	-	-	-	-	-	-	-

Operating Income
Operating Income	73.2	61.8	66.3	66.3	63.4	62.8	50.9	54.2	27.1	41.7	(37.2)	46.7	35.6	30.8	25.1	28.6	17.4	12.7	14.0	15.8	9.8	8.6	11.7	10.3	10.7	8.0	13.8	11.0	(1.0)	(14.8)	(8.2)	(6.3)	(5.9)	(5.5)	(4.3)	(4.2)	(4.7)	(4.3)	(3.9)	(4.8)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	11.0	10.1	4.8	3.0	7.9	11.3	6.3	1.5	2.0	5.0	(0.8)	1.8	1.7	2.2	0.9	(0.3)	0.1
Pre-Tax Income	84.2	71.9	71.0	69.3	71.3	74.2	57.2	55.8	29.1	46.7	(38.0)	48.5	37.3	33.0	26.0	28.2	17.5

Tax & Net
Income Tax Expense	20.5	19.2	18.3	17.2	14.5	18.2	13.3	15.0	5.8	11.9	(7.3)	10.8	7.7	7.5	3.3	6.6	4.2	3.5	3.7	3.7	2.2	(2.7)	(31.6)	0.6	0.6	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Income From Continuing Ops	63.7	52.7	52.8	52.1	56.7	55.9	43.9	40.8	23.3	34.8	(30.8)	37.8	29.6	25.5	22.7	21.6	13.2
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	63.7	52.7	52.8	52.1	56.7	55.9	43.9	40.8	23.3	34.8	(30.8)	37.8	29.6	25.5	22.7	21.6	13.2
Net Income Attributable To Parent	63.7	52.7	52.8	52.1	56.7	55.9	43.9	40.8	23.3	34.8	(30.8)	37.8	29.6	25.5	22.7	21.6
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	63.7	52.7	52.8	52.1	56.7	55.9	43.9	40.8	23.3	34.8	(30.8)	37.8	29.6	25.5	22.7

Per Share
EPS Basic	0.52	-	0.43	0.43	0.47	-	0.37	0.35	0.20	-	(0.29)	0.36	0.28	-	0.22	0.21	0.13	-	0.10	0.12	0.07	-	0.42	0.09	0.10	-	0.13	0.11	(0.01)	-	(0.08)	(0.06)	-	-	-	-	-	-	-	-
EPS Diluted	0.50	-	0.42	0.41	0.45	-	0.35	0.33	0.19	-	(0.29)	0.33	0.26	-	0.20	0.20	0.12	-
Shares Basic	122.3	-	122.6	122.2	121.5	-	118.9	118.2	116.8	-	106.6	106.3	105.6	-	103.3	102.8	102.8	-
Shares Diluted	126.9	-	127.1	127.5	127.0	-	125.4	124.7	123.4	-	106.6	113.7	114.0	-	112.0	109.3	109.0	-

Supplementary Data
EBITDA	73.3	-	-	-	63.5	-	-	-	27.2	-	-	-	35.7	-	-	-	17.4	-	-	-	9.9	-	-	-	10.7	-	13.9	-	(1.0)	(14.8)	(8.2)	(6.3)	(5.9)	(5.5)	(4.3)	(4.2)	(4.7)	(4.3)	(3.9)	(4.8)
EBIT	73.2	61.8	66.3	66.3	63.4	62.8	50.9	54.2	27.1	41.7	(37.2)	46.7	35.6	30.8	25.1	28.6	17.4	12.7	14.0

Operating Income
Operating Income	267.6	257.8	195.1	86.8	101.8	52.4	41.3	31.8	(35.3)	(18.7)	(19.3)	(20.4)	(14.6)	(10.3)	(5.2)	(6.1)	(4.0)	(7.3)	-	-	-	-	-	-	-

Tax & Net
Income Tax Expense	75.1	69.2	52.4	23.1	21.6	13.2	(33.1)	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	221.3	214.3	163.9	71.4	83.1	39.5	75.0	31.9	(34.0)	(18.4)	(18.1)	(20.2)	(15.5)	(12.2)	(4.1)	(6.4)	(4.0)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	221.3	214.3	163.9	71.4	83.1	39.5	75.0	31.9	(34.0)	(18.4)	(18.1)	(20.2)	(15.5)	(12.2)	(4.1)	(6.4)	(4.0)
Net Income Attributable To Parent	221.3	214.3	163.9	71.4	83.1	39.5	75.0	31.9	(34.0)	(18.4)	(18.1)	(20.2)	(15.5)	(12.2)	(4.1)	(6.4)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	221.3	214.3	163.9	71.4	83.1	39.5	75.0	31.9	(34.0)	(18.4)	(18.1)	(20.2)	(15.5)	(12.2)	(4.1)

Per Share
EPS Basic	1.81	1.75	1.38	0.67	0.80	0.38	0.72	0.31	(0.33)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	1.74	1.68	1.31	0.63	0.75	0.37	0.71	0.30	(0.33)	-	-	-	-	-	-	-	-	-
Shares Basic	122.3	122.3	118.5	106.3	103.4	103.4	103.5	102.9	102.6	-	-	-	-	-	-	-	-	-
Shares Diluted	126.9	127.3	124.9	113.8	111.4	107.8	106.2	106.0	102.6	-	-	-	-	-	-	-	-	-

Supplementary Data
EBITDA	-	258.2	195.5	87.1	102.0	52.6	41.4	31.9	(35.3)	(18.6)	(19.2)	(20.4)	(14.6)	(10.3)	(5.2)	(6.0)	(4.0)	(7.2)	-	-	-	-	-	-	-
EBIT	267.6	257.8	195.1	86.8	101.8	52.4	41.3	31.8	(35.3)	(18.7)	(19.3)	(20.4)	(14.6)	(10.3)	(5.2)	(6.1)	(4.0)	(7.3)	-